Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session

Published 17/08/2022, 17:03
Updated 17/08/2022, 17:40
© Reuters.  Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session

Gainers

  • Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus shell and protrusion virus-like particle platform.
  • Hill International, Inc. (NYSE: HIL) shares rose 61.5% to $2.81 after Global Infrastructure Solutions (GISI) and the company announced an agreement to merge in an all-cash transaction valued at $173 million.
  • JE Cleantech Holdings Limited (NASDAQ: JCSE) shares jumped 54% to $3.50 after jumping over 20% on Tuesday.
  • Eargo, Inc. (NASDAQ: EAR) rose 46.3% to $2.9550 after climbing 77% on Tuesday. Eargo recently said Q2 EPS results were down year over year.
  • Cassava Sciences, Inc. (NASDAQ: SAVA) gained 40.4% to $28.37 after a form 4 filing showed Director Sanford Robertson purchased 100,000 shares at an average price of $20.69.
  • Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 31.9% to $1.4908. Vinco Ventures shares jumped around 59% on Tuesday after Nasdaq resumed trading in the stock.
  • Bed Bath & Beyond Inc (NASDAQ: BBBY) rose 24% to $25.59 on continued momentum amid an uptick in retail investor attention on social media.
  • Laird Superfood, Inc. (NYSE: LSF) gained 21.7% to $2.7399 after the company confirmed the receipt of an unsolicited offer from EF Hutton to acquire all of the company's outstanding common stock for $3 per share in cash.
  • LexinFintech Holdings Ltd. (NASDAQ: LX) jumped 21.6% to $2.4199 after the company late Tuesday reported Q2 results.
  • Stabilis Solutions, Inc. (NASDAQ: SLNG) rose 17.7% to $5.40. The company recently posted upbeat quarterly sales.
  • Akumin Inc. (NASDAQ: AKU) gained 17.6% to $1.0850.
  • Cogent Biosciences, Inc. (NASDAQ: COGT) rose 16.5% to $16.50. Cogent Biosciences recently posted a Q2 loss of $0.71 per share.
  • ATA Creativity Global (NASDAQ: AACG) gained 16% to $2.46. ATA Creativity Global recently posted a Q2 loss of $0.05 per share.
  • TDH Holdings, Inc. (NASDAQ: PETZ) jumped 15.8% to $3.57.
  • Longboard Pharmaceuticals, Inc. (NASDAQ: LBPH) gained 15.5% to $4.98.
  • Qilian International Holding Group Limited (NASDAQ: QLI) jumped 13.4% to $1.52.
  • Kubient, Inc. (NASDAQ: KBNT) jumped 13% to $1.0852. Kubient recently reported worse-than-expected Q2 EPS and sales results.
  • Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) gained 12.5% to $3.51. Reneo Pharmaceuticals recently posted a Q2 loss of $0.50 per share.
  • FaZe Holdings Inc. (NASDAQ: FAZE) rose 8.3% to $14.42 after gaining 12% on Tuesday. The company reported Q2 results on Monday.
  • BlackLine, Inc. (NASDAQ: BL) gained 8% to $74.69.
  • Kirkland's, Inc. (NASDAQ: KIRK) gained 7.7% to $5.70.
  • Agilent Technologies, Inc. (NYSE: A) rose 6.9% to $141.88 after the company reported better-than-expected results for its third quarter and raised its FY22 guidance.
Losers
  • Scienjoy Holding Corporation (NASDAQ: SJ) shares dipped 25.6% to $3.26.
  • Embark Technology, Inc. (NASDAQ: EMBK) fell 25.1% to $12.40. Embark Technology reported the completion of reverse stock split.
  • Sonder Holdings Inc. (NASDAQ: SOND) declined 23.1% to $1.96.
  • Blueprint Medicines Corporation (NASDAQ: BPMC) fell 22.5% to $53.11 after the company announced top-line results from the registrational Part 2 of the PIONEER clinical trial of AYVAKIT in patients with non-advanced systemic mastocytosis.
  • Artelo Biosciences, Inc. (NASDAQ: ARTL) shares dipped 22% to $4.96. Artelo Biosciences shares jumped 46% on Tuesday after the company announced the publication of pre-clinical results of its FABP inhibitor platform.
  • Stronghold Digital Mining, Inc. (NASDAQ: SDIG) shares fell 21.8% to $2.4950 after the company reported worse-than-expected Q2 sales results.
  • Lulu's Fashion Lounge Holdings, Inc. (NASDAQ: LVLU) tumbled 21.6% to $6.14 after the company reported worse-than-expected Q2 EPS. Piper Sandler lowered its price target on the stock from $14 to $11.
  • PAVmed Inc. (NASDAQ: PAVM) dropped 21.2% to $1.5606 after the company issued business update and preliminary Q2 financial results. Lake Street maintained PAVmed with a Buy and lowered the price target from $7 to $5.
  • Unity Biotechnology, Inc. (NASDAQ: UBX) declined 20% to $1.0950 after the company announced a $25 million common stock offering.
  • Kidpik Corp. (NASDAQ: PIK) shares fell 19% to $2.0500 after the company reported worse-than-expected Q2 sales results.
  • Nerdy, Inc. (NYSE: NRDY) declined 18.6% to $3.0512. Goldman Sachs (NYSE:GS) maintained Nerdy with a Neutral and raised the price target from $3 to $3.5.
  • Four Seasons Education (Cayman) Inc. (NYSE: FEDU) dipped 18% to $14.51.
  • Singular Genomics Systems, Inc. (NASDAQ: OMIC) declined 17.6% to $3.31 after UBS downgraded the stock from Buy to Neutral and lowered its price target from $10 to $4.50.
  • BioAtla, Inc. (NASDAQ: BCAB) dropped 17.7% to $9.76.
  • Palisade Bio, Inc. (NASDAQ: PALI) fell 17% to $0.1716. Palisade Bio dosed first patient in its Phase 3 study evaluating lead asset LB1148 to accelerate the return of bowel function in adult patients undergoing gastrointestinal surgery.
  • Iterum Therapeutics plc (NASDAQ: ITRM) declined 15.8% to $0.2316. Iterum Therapeutics on Tuesday announced August 17, 2022 as date of 1-for-15 reverse share split.
  • I-Mab (NASDAQ: IMAB) fell 15.5% to $6.73. I-Mab disclosed in an SEC filing that AbbVie Inc (NYSE: NYSE:ABBV) would discontinue the global Phase 1b study of lemzoparlimab combination therapy with azacitidine and venetoclax in myelodysplastic syndrome (MDS) and acute myelocytic leukemia (AML).
  • Enovix Corporation (NASDAQ: ENVX) dipped 15% to $21.20.
  • Everspin Technologies, Inc. (NASDAQ: MRAM) dropped 15% to $7.43.
  • Krispy Kreme, Inc. (NASDAQ: DNUT) fell 14.6% to $12.39 after the company reported worse-than-expected Q2 EPS and sales results and issued FY22 adjusted EPS and sales guidance below estimates.
  • Membership Collective Group Inc. (NYSE: MCG) dropped 14.6% to $6.98 after the company lowered FY22 sales forecast.
  • FlexShopper, Inc. (NASDAQ: FPAY) fell 14.3% to $2.1598.
  • Latham Group, Inc. (NASDAQ: SWIM) dipped 14.2% to $6.70.
  • The Children's Place, Inc. (NASDAQ: PLCE) fell 14.2% to $47.15 after the company reported a year-over-year drop in Q2 sales.
  • Arvinas, Inc. (NASDAQ: ARVN) fell 13.8% to $45.19.
  • HyreCar Inc. (NASDAQ: HYRE) declined 12.3% to $1.14. HyreCar recently posted a Q2 loss of $0.20 per share.
  • Amyris, Inc. (NASDAQ: AMRS) fell 12% to $3.23.
  • Endo International plc (NASDAQ: ENDP) fell 11.6% to $0.3271. Endo International filed for bankruptcy after reaching a $6 billion deal with some of its creditors as the company sought to settle opioid-related lawsuits.
  • Farfetch Limited (NYSE: FTCH) dipped 10.7% to $8.92.
  • The RealReal, Inc. (NASDAQ: REAL) fell 10.5% to $3.0150 after jumping 22% on Tuesday.
  • Opendoor (NASDAQ:OPEN) Technologies Inc. (NASDAQ: OPEN) declined 9.7% to $5.13.
  • Teva Pharmaceutical Industries Limited (NASDAQ: NYSE:TEVA) dropped 9.6% to $9.98.
  • ZipRecruiter, Inc. (NYSE: ZIP) fell 9.6% to $17.93.
  • Tuesday Morning Corporation (NASDAQ: TUEM) fell 8.4% to $0.3152. Tuesday Morning recently reported CFO transition.
  • Novavax, Inc. (NASDAQ: NVAX) declined 7.8% to $39.53. Novavax Nuvaxovid COVID-19 vaccine was granted expanded provisional approval in New Zealand as a first and second booster for adults.
  • Sanofi (EPA:SASY) (NASDAQ: SNY) fell 7.6% to $41.42 after the company announced it is discontinuing the global clinical development program of amcenestrant following the recommendation of an Independent Data Monitoring Committee.
  • Snap Inc . (NYSE: NYSE:SNAP) dropped 7.1% to $11.72.
  • Lyft , Inc. (NASDAQ: NASDAQ:LYFT) declined 7% to $18.00.
  • Zoom Video Communications, Inc. (NASDAQ: ZM) fell 6.3% to $102.35. Shares of software companies traded lower amid a rise in treasury yields, which weighed on growth stocks.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.